Current Issue : July-September Volume : 2023 Issue Number : 3 Articles : 2 Articles
The numerous bacteria species have developed worrisome rates of resistance to different antimicrobial treatments, posing a threat to the global public health. Even though the emergence of multi-drug resistant infections is a natural phenomenon, improper antimicrobial drug use, unsanitary living conditions, inappropriate antibiotic use and inadequate infection prevention and control procedures all contribute to its development. Here, we discussed an instance of an infection that appeared to be resistant to multiple antibiotics. In order to prevent illnesses that are resistant to several drugs, the goal is to raise knowledge about resistance and encourage the wise use of antibiotics and chemists' role in halting the spread of antibiotic resistance. Here the case report says, a 73-year-old woman who had a right cemented bipolar hip replacement and an intracapsular fracture of the neck of the femur was admitted to the orthopaedic department of General Hospital with bleeding from the surgery site for a few days. Due to her resistance to low grade doses of antibiotics, she was prescribed with high level of antibiotics such ceftazidime-avibactam (2g+0.5g) and aztreonam (1g)....
The world got affected by Covid-19 virus in the start of 2020 and till now, its effect has not subsided. India was specifically affected and accounted for 16.85% of the world’s cases. This pandemic hit the world in waves or phases and in India, the peak of the first wave was experienced in September while the healthcare system in India, anticipated the impending second wave. This research focuses on the determination of the safety and effectiveness profile of the ivermectin drug in the management of Covid-19. The objective of the systematic review is to determine the safety and effectiveness of ivermectin in the management of Covid-19. The effectiveness profile of ivermectin for mild, moderate and severe symptoms of Covid-19 were analysed ,with more importance given to accessing the improvement of the related blood parameters, fever, anosmia (loss of smell), aguesia (loss of taste), respiratory symptoms, gastrointestinal symptoms, reduction in mortality rate and improvement in survival rate. In this systematic review, it was concluded that the administration of ivermectin to Covid-19 infected patients was and is still highly beneficial, as mortality rate was reduced, survival rate was increased, symptoms were improved and it was highly safe with only minor adverse effects recorded....
Loading....